- “Medarex gets payment after Ilaris approval” (Forbes)
- “CytRx files FDA report on halted clinical trial” (MarketWatch)
- “J&J unit gets $1.67 billion verdict vs Abbott Labs” (The Associated Press)
- “Collegium Pharmaceutical Announces the Sale of AllerNaze™ to Lupin” (Press release issued by Collegium Pharmaceuticals, BusinessWire)
- “BioScrip Commences Patient Enrollment in Teva Neuroscience Therapy Optimization in Multiple Sclerosis (Tops MS) Research Study” (Press release issued by BioScrip and Teva Neuroscience, BusinessWire)
- “AstraZeneca: Pozen submits Vimovo NDA application” (Market Watch)
- “Abbott Labs loses $1.7 billion Humira patent lawsuit to Johnson & Johnson” (Chicago Tribune)
- “FDA panel to vote on painkiller restrictions” (The Associated Press)
- “Obama-Proof: Pfizer, Bristol-Myers and Teva” (TheStreet.com)
- “EU regulator extends review of Pfizer/Wyeth deal” (Reuters)
- “Teva, biotech firm partner to make cancer drugs work” (Reuters)
THE LATEST WORD
Top Industry Stories – June 30, 2009
Posted on June 30th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics